International Drug Scheduling; Convention on Psychotropic Substances; World Health Organization Scheduling Recommendations for Gamma-hydroxybutyric Acid

Summary

The U.S. Food and Drug Administration (FDA) invites public comments and requests for a meeting to discuss the World Health Organization's (WHO) proposal to restrict the international manufacturing and distribution of certain psychotropic substances, including gamma-hydroxybutyric acid, under international treaties. The comments will inform the U.S. position on these proposals for a United Nations Commission on Narcotic Drugs (CND) meeting in Vienna, Austria, in March 2013.